Abstract
Background
Treatment of HCV with direct-acting antivirals has enabled the discussion of HCV eradication worldwide. Envisioning this aim requires implementation of mass screening in resource-limited areas, usually constrained by testing costs.
Methods
We validated a low-cost, rapid diagnosis test (RDT) for HCV in three different continents in 141 individuals.
Results
The HCV RDT showed 100% specificity and sensitivity across different samples regardless of genotype or viral load (in samples with such information, 90%).
Conclusions
The HCV test validated in this study can allow for HCV screening in areas of need when properly used.
Management of Severe Malaria and Severe Dengue in Resource-Limited Settings
